Vojislav Đukić

Vojislav Đukić

Auto-generated profile, based on publicly available information

Vojislav Đukić

Clinic of Gastroenterology and Hepatology, University Clinical Centre Kragujevac, Kragujevac, Serbia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
PDF file
NĆNeda Ćićarić
Neda Ćićarić
VĐVojislav Đukić
Vojislav Đukić
Resistant hypertension (RH) is disproportionately prevalent in patients with chronic kidney disease (CKD) and is strongly associated with accelerated cardiovascular morbidity and CKD progression. Emerging evidence suggests that gastrointestinal dysbiosis may represent a modifiable contributor to RH through multiple converging mechanisms, including accumulation of protein-bound uremic toxins, impaired short-chain fatty acid signaling, heightened systemic inflammation and oxidative stress, sympathetic activation, altered bile acid metabolism, increased intestinal permeability, and microbe–drug interactions that attenuate antihypertensive efficacy. This review synthesizes mechanistic, clinical, and translational evidence linking gut dysbiosis to RH in CKD, with a focus on therapeutic strategies and unmet needs. Finally, critical research gaps were outlined and a pragmatic agenda was proposed for translational studies and precision microbiome-guided interventions aimed at improving blood pressure control and cardiovascular-renal outcomes. Cite this article as: Ćićarić N, Đukić V. Gastrointestinal dysbiosis and resistant hypertension in chronic kidney disease: mechanisms, clinical evidence, and therapeutic perspectives. Turk J Nephrol. Published online May 22, 2026. doi: 10.5152/turkjnephrol.2025.251200.